Impact of surfactant selection on the formulation and characterization of microparticles for pulmonary drug delivery

References

• Tans Y, Yang Z, Peng F, et al. A novel bottom-up process to produce nanoparticles containing protein and peptide for suspension in hydrofluoroalkane propellants. Int J Pharm 2011;413:167–73
   PubMedGoogle Scholar
• Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm 2010;392:1–19
   PubMed Web of Science ®Google Scholar
• Wall DA. Pulmonary absorption of peptides and proteins. Drug Deliv 1995;2:1–20
   Google Scholar
• Edwards DA, Hanes J, Caponetti G, et al. Large porous particles for pulmonary drug delivery. Science 1997;276:1868–71
   PubMed Web of Science ®Google Scholar
• Ungaro F, d’Emmanuele di Villia Bianca R, Giovino C, et al. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolisation properties: in-vivo deposition and hypoglycaemic activity after delivery to rat lungs. J Control Release 2009;135:25–34
   PubMed Web of Science ®Google Scholar
• Ben-Jebria A, Eskew ML, Edwards DA. Inhalation system for pulmonary aerosol drug delivery in rodents using large porous particles. Aerosol Sci Technol 2000;32:421–33
   Web of Science ®Google Scholar
• Sakagami M, Sakon K, Kinoshita W, Makino Y. Enhanced pulmonary absorption following aerosol administration of mucoadhesive powder microspheres. J Control Release 2001;77:117–29
   PubMed Web of Science ®Google Scholar
• Mao S, Xu J, Cai C, et al. Effect of WOW process parameters on morphology and burst release of FITC-Dextran laoded PLGA microspheres. Int J Pharm 2007;334:137–48
   PubMed Web of Science ®Google Scholar
• Sivadas N, O’Rourke D, Tobin A, et al. A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm 2008;358:159–67
   PubMed Web of Science ®Google Scholar
• Givagnoli S, Blasi P, Schoubben A, et al. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulphate pulmonary delivery. Int J Pharm 2007;333:103–11
   PubMedGoogle Scholar
• Sun L, Zhou S, Wang W, et al. Preparation and characterization of porous biodegradable microspheres used for controlled protein delivery. Colloids Surfaces A Physicochem Eng Aspects 2009;345:173–81
   Web of Science ®Google Scholar
• Hamishehkar H, Emami J, Najafabadi A, et al. Effect of carrier morphology and surface characteristics on the development of respirable PLGA microcapsules for sustained-release pulmonary delivery of insulin. Int J Pharm 2010;389:74–85
   PubMed Web of Science ®Google Scholar
• Conway BR, Alpar HO. Double emulsion microencapsulation of proteins as model antigens using polylactide polymers: effect of emulsifier on the microsphere characteristics and release kinetics. Eur J Pharm Biopharm 1996;42:42–8
   Web of Science ®Google Scholar
• Spiers ID, Eyles JE, Baillie LWJ, et al. Biodegradable microparticles with different release profiles: effect of the immune response after single administration via intranasal and intramuscular routes. J Pharm Pharmacol 2000;52:1195–201
   PubMed Web of Science ®Google Scholar
• Rafi MD, Singh SM, Kanchan V, et al. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles. J Microencapsul 2010;27:552–60
   PubMed Web of Science ®Google Scholar
• Choi HS, Seo S, Khang G, et al. Preparation and characterisation of fentanyl-loaded PLGA microspheres: in-vitro release profiles. Int J Pharm 2002;234:195–203
   PubMed Web of Science ®Google Scholar
• Jeyanthi R, Mehta RC, Thanoo BC, DeLuca PP. Effect of solvent removal technique on the matrix characteristics of polylactide/glycolide microspheres for peptide delivery. J Control Release 1996;38:235–44
   Web of Science ®Google Scholar
• DeLuca PP, Kanke M, Sato T, Schroeder HG. Porous microspheres for drug delivery and methods for making the same. 1989; US Patent 4,818,542
   Google Scholar
• Jeffery H, Davis SS, O’Hagan DT. The preparation and characterisation of poly(lactide-co-glycolide) microparticles. Π. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res 1993;10:362–8
   PubMed Web of Science ®Google Scholar
• Crotts G, Park TG. Preparation of porous and non-porous biodegradable polymeric hollow microspheres. J Control Release 1995;35:91–105
   Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of PLGA nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm 1999;187:143–52
   PubMed Web of Science ®Google Scholar
• Arshady R. Preparation of biodegradable microspheres and microcapsules: 2. Polyactides and related polyesters. J Control Release 1991;17:1–22
   Web of Science ®Google Scholar
• Sato T, Kanke M, Schroeder HG, DeLuca PP. Porous biodegradable microspheres for controlled drug delivery. 1. Assessment of processing conditions and solvent removal techniques. Pharm Res 1988;5:21–30
   PubMed Web of Science ®Google Scholar
• Ehtezazi T, Washington C. Controlled release of macromolecules from PLA microspheres: using porous structure topography. J Control Release 2000;68:361–72
   PubMed Web of Science ®Google Scholar
• Freitas S, Merkle HP, Gander B. Microencapsulation by solvent extraction/evaporation: reviewing the state of the art of microsphere preparation and process technology. J Control Release 2005;102:313–32
   PubMed Web of Science ®Google Scholar
• Lee J, Oh YJ, Lee SK, Lee KY. Facile control of porous structures of polymer microspheres using an osmotic agent for pulmonary drug delivery. J Control Release 2010;146:61–7
   PubMed Web of Science ®Google Scholar
• Gaignaux A, Reeff J, Siepmann F, et al. Development and evaluation of sustained-release clonidine-loaded PLGA microparticles. Int J Pharm 2012;437:20–8
   PubMed Web of Science ®Google Scholar
• Li W, Anderson KW, Mehta RC, DeLuca PP. Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/evaporation method. J Control Release 1995;37:199–214
   Web of Science ®Google Scholar
• Rafati H, Coombes AGA, Alder J, et al. Protein-loaded poly(DL-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. J Control Release 1997;43:89–102
   Web of Science ®Google Scholar
• De Rosa G, Iommelli R, La Rotonda MI, et al. Influence of the co-encapsulation of different non-ionic surfactants on the properties of PLGA insulin-loaded microspheres. J Control Release 2000;69:283–95
   PubMed Web of Science ®Google Scholar
• Blanco D, Alonso M. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of co-encapsulation of surfactants. Eur J Pharm Biopharm 1987;45:285–94
   Google Scholar
• Nihant N, Schugens C, Grandfils C, et al. Polylactide microparticles prepared by double emulsion/evaporation technique. 1. Effect of primary emulsion stability. Pharm Res 1994;11:1479–84
   PubMed Web of Science ®Google Scholar
• Nyamburai B, Kellaway IW, Taylor MG. The processing of nanoparticles containing protein for suspension in hydrofluoalkane propellants. Int J Pharm 2009;372:140–6
   PubMedGoogle Scholar
• Bodmeier R, McGinity JW. The preparation and evaluation of drug-containing poly(dl-lactide) microspheres formed by the solvent evaporation method. Pharm Res 1987;4:465–71
   PubMed Web of Science ®Google Scholar
• Li X, Deng X, Yuan M, et al. Investigation on process parameters involved in the preparation of poly-DL-lactide-poly(ethylene glycol) microspheres containing Leptospira Interrogans antigens. Int J Pharm 1999;178:245–55
   PubMed Web of Science ®Google Scholar
• Yang Y, Chung T, Ng NP. Morphology, drug distribution, and in-vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by a double-emulsion solvent extraction/evaporation method. Biomaterials 2001;22:231–41
   PubMed Web of Science ®Google Scholar
• Yan C, Resau JH, Hewetson J, et al. Characterisation and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-in-water emulsion technique. J Control Release 1994;32:231–41
   Web of Science ®Google Scholar
• Schlicher EJAM, Postma NS, Zuidema J, et al. Preparation and characterisation of poly(D,L-lactic-co-glycolic acid) microspheres containing desferrioxamine. Int J Pharm 1997;153:235–45
   Web of Science ®Google Scholar
• Mohamed F, Van der Walle CF. PLGA microcapsules with novel dimpled surfaces for pulmonary delivery of DNA. Int J Pharm 2006;311:97–107
   PubMed Web of Science ®Google Scholar
• Freiberg S, Zhu XX. Polymer microspheres for controlled drug release. Int J Pharm 2004;282:1–18
   PubMed Web of Science ®Google Scholar
• Florence AT, Whitehill D. The formulation and stability of multiple emulsions. Int J Pharm 1982;11:277–308
   Web of Science ®Google Scholar
• Ghaderi R, Sturesson C, Carlfors J. Effect of preparative parameters on the characteristics of poly(D,L-lactide-co-glycolide) microspheres made by the double emulsion method. Int J Pharm 1996;141:205–16
   Web of Science ®Google Scholar
• Cleland JL, Lim A, Barrón L, et al. Development of a single-shot subunit vaccine for HIV-1: Part 4. Optimising microencapsulation and pulsatile release of MN rgp 120 from biodegradable microspheres. J Control Release 1997;47:135–50
   Web of Science ®Google Scholar
• Tamber H, Johansen P, Merkle HP, Gander B. Formulation aspects of biodegradable microspheres for antigen delivery. Adv Drug Deliv Rev 2005;57:357–76
   PubMed Web of Science ®Google Scholar
• Mandal TK, Bostanian LA, Graves RA, et al. Porous biodegradable microparticles for delivery of pentamidine. Eur J Pharm Biopharm 2001;52:91–6
   PubMed Web of Science ®Google Scholar